ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

GPCR Structure Therapeutics Inc

46.75
-0.77 (-1.62%)
Fuera de horario
Última actualización: 17:43:31
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Structure Therapeutics Inc GPCR NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.77 -1.62% 46.75 17:43:31
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
46.91 45.40 48.12 46.75 47.52
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/6/202415:05GLOBEStructure Therapeutics Announces Closing of Upsized Public..
06/6/202415:17EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/6/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
05/6/202418:53GLOBEStructure Therapeutics Announces Pricing of Upsized $476..
05/6/202418:43EDGAR2Form S-1MEF - Registration adding securities to prior Form..
05/6/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:59EDGAR2Form 8-K - Current report
03/6/202415:58EDGAR2Form 144 - Report of proposed sale of securities
03/6/202415:09GLOBEStructure Therapeutics Announces Proposed Public Offering of..
03/6/202415:02EDGAR2Form S-1 - General form for registration of securities under..
03/6/202407:00EDGAR2Form 8-K - Current report
03/6/202406:30GLOBEStructure Therapeutics Reports Positive Topline Data from..
09/5/202415:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:10EDGAR2Form 8-K - Current report
09/5/202415:05GLOBEStructure Therapeutics Reports First Quarter 2024 Financial..
08/3/202415:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202415:05GLOBEStructure Therapeutics to Present at Leerink Partners Global..
08/3/202408:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202407:43EDGAR2Form 8-K - Current report
08/3/202407:30GLOBEStructure Therapeutics Reports Fourth Quarter and Full Year..
18/12/202307:28EDGAR2Form 8-K - Current report
18/12/202306:30GLOBEStructure Therapeutics Provides Comprehensive GSBR-1290..
17/11/202316:25EDGAR2Form S-1 - General form for registration of securities under..
17/11/202315:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/11/202315:51EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
16/11/202316:13EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
14/11/202315:10GLOBEStructure Therapeutics Reports Third Quarter 2023 Financial..
29/9/202306:50EDGAR2Form 8-K - Current report
29/9/202306:38EDGAR2Form 8-K - Current report
29/9/202306:32GLOBEStructure Therapeutics Announces $300 Million Private..
29/9/202306:30GLOBEStructure Therapeutics Announces Positive Results from Phase..
10/8/202315:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:19EDGAR2Form 8-K - Current report
10/8/202315:05GLOBEStructure Therapeutics Reports Second Quarter 2023 Financial..
04/8/202315:30EDGAR2Form 8-K - Current report
03/8/202316:32GLOBEStructure Therapeutics Appoints Ted W. Love, M.D., to Board..
06/7/202315:05EDGAR2Form 8-K - Current report

Su Consulta Reciente